Catalent Inc (NASDAQ:CTLT) – Stock analysts at William Blair issued their Q1 2018 EPS estimates for shares of Catalent in a research report issued on Tuesday. William Blair analyst J. Kreger expects that the company will post earnings per share of $0.19 for the quarter. William Blair has a “Ourperform” rating on the stock. William Blair also issued estimates for Catalent’s Q2 2018 earnings at $0.35 EPS, Q3 2018 earnings at $0.36 EPS and Q4 2018 earnings at $0.60 EPS.

Other research analysts also recently issued research reports about the stock. Wells Fargo & Company reaffirmed an “outperform” rating and issued a $39.00 price objective (up previously from $30.00) on shares of Catalent in a research report on Thursday. Bank of America Corporation reaffirmed a “buy” rating and issued a $40.00 price objective (up previously from $38.00) on shares of Catalent in a research report on Tuesday. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $45.00 price objective on shares of Catalent in a research report on Tuesday. Zacks Investment Research downgraded shares of Catalent from a “buy” rating to a “hold” rating in a research report on Friday, August 18th. Finally, Jefferies Group LLC reaffirmed a “hold” rating and issued a $38.00 price objective (up previously from $35.00) on shares of Catalent in a research report on Tuesday. Three equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $36.22.

ILLEGAL ACTIVITY WARNING: This piece of content was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/09/01/catalent-inc-ctlt-forecasted-to-earn-q1-2018-earnings-of-0-19-per-share.html.

Catalent (NASDAQ CTLT) opened at 41.29 on Thursday. Catalent has a 52 week low of $21.83 and a 52 week high of $41.40. The company has a market cap of $5.17 billion and a P/E ratio of 47.46. The stock has a 50 day moving average of $35.50 and a 200 day moving average of $32.67.

Catalent (NASDAQ:CTLT) last issued its earnings results on Monday, August 28th. The company reported $0.65 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.57 by $0.08. The firm had revenue of $616.90 million for the quarter, compared to the consensus estimate of $547.48 million. Catalent had a net margin of 4.88% and a return on equity of 16.95%. The business’s revenue was up 15.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.52 earnings per share.

A number of hedge funds have recently added to or reduced their stakes in CTLT. Advisor Group Inc. boosted its stake in Catalent by 1.3% in the second quarter. Advisor Group Inc. now owns 5,185 shares of the company’s stock worth $180,000 after buying an additional 65 shares during the period. Stifel Financial Corp boosted its stake in Catalent by 0.9% in the second quarter. Stifel Financial Corp now owns 10,694 shares of the company’s stock worth $377,000 after buying an additional 96 shares during the period. Massachusetts Financial Services Co. MA boosted its stake in Catalent by 1.2% in the first quarter. Massachusetts Financial Services Co. MA now owns 10,909 shares of the company’s stock worth $309,000 after buying an additional 130 shares during the period. Aperio Group LLC boosted its stake in Catalent by 0.8% in the second quarter. Aperio Group LLC now owns 23,088 shares of the company’s stock worth $810,000 after buying an additional 190 shares during the period. Finally, Capstone Asset Management Co. boosted its stake in Catalent by 2.3% in the second quarter. Capstone Asset Management Co. now owns 10,130 shares of the company’s stock worth $356,000 after buying an additional 230 shares during the period.

In related news, SVP Christine Dolan sold 1,594 shares of Catalent stock in a transaction that occurred on Tuesday, August 29th. The shares were sold at an average price of $38.75, for a total value of $61,767.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Catalent Company Profile

Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.

Earnings History and Estimates for Catalent (NASDAQ:CTLT)

Receive News & Stock Ratings for Catalent Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent Inc and related stocks with our FREE daily email newsletter.